Table 2.
Compounds | Viability (%) | |
---|---|---|
50 µg mL−1 | 100 µg mL−1 | |
3-Carene | 84.1 ± 6.4 ** | 48.7 ± 6.7 * |
Carvacrol | 51.3 ± 3.0 | 46.1 ± 2.9 * |
(−)-Carvone | 65.1 ± 4.7 | 58.2 ± 4.2 |
1,8-Cineole | 71.4 ± 0.7 | 66.9 ± 7.8 |
Eugenol | 78.1 ± 7.0 | 63.1 ± 1.7 |
Isoborneol | 73.3 ± 9.4 | 72.9 ± 7.5 |
(−)-Linalool | 65.7 ± 8.2 | 66.7 ± 7.8 |
(−)-Menthol | 83.8 ± 8.0 ** | 81.2 ± 2.4 ** |
Thymol | 64.5 ± 4.0 | 58.5 ± 6.7 |
p-Cymene | 91.2 ± 6.6 ** | 87.1 ± 6.7 ** |
Low cytotoxicity (viability between >50% and <80%); * Moderate cytotoxicity (viability between >30% and <50%); and ** Non-cytotoxic (viability >80%).